People: Acceleron Pharma Inc (XLRN.O)
23 Jun 2017
Dr. Ravindra Kumar, Ph.D., is Senior Vice President, Chief Scientific Officer of Acceleron Pharma, Inc. He joined Acceleron in March 2004 and is currently our Senior Vice President and Chief Scientific Officer. Dr. Kumar established and currently leads our discovery research. Previously, Dr. Kumar worked for 12 years at Genetics Institute and Wyeth Pharmaceuticals. At Genetics Institute, Dr. Kumar was a key member of the Small Molecule Drug Discovery group and was responsible for cell biology. Following the integration of discovery functions from Genetics Institute and Wyeth Pharmaceuticals, Dr. Kumar served as Senior Scientist in the Biological Chemistry group. Dr. Kumar is the author of several key scientific manuscripts in the area of protein glycosylation and is named as an inventor of several patents. Dr. Kumar received his BS in chemistry from Rohilkhand University, his MS in chemistry from Meerut University, his Ph.D. from University of New Brunswick and he completed his post-doctoral fellowship at Albert Einstein College of Medicine, in Bronx, NY.
|Total Annual Compensation, USD||355,000|
|Restricted Stock Awards, USD||167,820|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||730,489|
|Fiscal Year Total, USD||1,253,310|